Literature DB >> 25023005

Expression and putative functions of melatonin receptors in malignant cells and tissues.

Cem Ekmekcioglu1.   

Abstract

Melatonin, the popular hormone of the darkness, is primarily synthesized in the pineal gland, and acts classically through the G-protein coupled plasma membrane melatonin receptors MT1 and MT2, respectively. Although some of the receptor mediated functions of melatonin, especially those on the (central) circadian system, have been more or less clarified, the functional meaning of MT-receptors in various peripheral organs are still not sufficiently investigated yet. There is, however, accumulating evidence for oncostatic effects of melatonin with both, antioxidative and MT-receptor mediated mechanisms possibly playing a role. This review briefly summarizes the physiology of melatonin and MT-receptors, and discusses the expression and function of MT-receptors in human cancer cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023005     DOI: 10.1007/s10354-014-0289-6

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  106 in total

1.  A relationship between heat loss and sleepiness: effects of postural change and melatonin administration.

Authors:  K Kräuchi; C Cajochen; A Wirz-Justice
Journal:  J Appl Physiol (1985)       Date:  1997-07

Review 2.  Melatonin receptor agonists: new options for insomnia and depression treatment.

Authors:  Gilberto Spadoni; Annalida Bedini; Silvia Rivara; Marco Mor
Journal:  CNS Neurosci Ther       Date:  2011-12       Impact factor: 5.243

3.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

4.  The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system.

Authors:  Tolga Uz; Ahmet D Arslan; Murat Kurtuncu; Marta Imbesi; Mustafa Akhisaroglu; Yogesh Dwivedi; Ghanshyam N Pandey; Hari Manev
Journal:  Brain Res Mol Brain Res       Date:  2005-05-20

5.  Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity.

Authors:  A Rimler; Z Culig; G Levy-Rimler; Z Lupowitz; H Klocker; H Matzkin; G Bartsch; N Zisapel
Journal:  Prostate       Date:  2001-10-01       Impact factor: 4.104

6.  MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.

Authors:  Lin Yuan; April R Collins; Jun Dai; Margarita L Dubocovich; Steven M Hill
Journal:  Mol Cell Endocrinol       Date:  2002-06-28       Impact factor: 4.102

Review 7.  Melatonin receptors in humans: biological role and clinical relevance.

Authors:  C Ekmekcioglu
Journal:  Biomed Pharmacother       Date:  2006-02-20       Impact factor: 6.529

8.  Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue.

Authors:  Dionne C Dillon; Samantha E Easley; Bonnie B Asch; Richard T Cheney; Lena Brydon; Ralf Jockers; Janet S Winston; John S Brooks; Thelma Hurd; Harold L Asch
Journal:  Am J Clin Pathol       Date:  2002-09       Impact factor: 2.493

9.  Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.

Authors:  Osamu Uchikawa; Kohji Fukatsu; Ryosuke Tokunoh; Mitsuru Kawada; Kiyoharu Matsumoto; Yumi Imai; Shuji Hinuma; Koki Kato; Hisao Nishikawa; Keisuke Hirai; Masaomi Miyamoto; Shigenori Ohkawa
Journal:  J Med Chem       Date:  2002-09-12       Impact factor: 7.446

10.  Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.

Authors:  Gabriela Oprea-Ilies; Erhard Haus; Linda Sackett-Lundeen; Yuan Liu; Lauren McLendon; Robert Busch; Amy Adams; Cynthia Cohen
Journal:  Breast Cancer Res Treat       Date:  2012-12-19       Impact factor: 4.872

View more
  5 in total

1.  Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca2+ influx and inflammatory cytokine molecular pathways in the docetaxel-treated mice by melatonin and selenium treatments.

Authors:  Zeki Serdar Ataizi; Kemal Ertilav; Mustafa Nazıroğlu
Journal:  Metab Brain Dis       Date:  2019-06-13       Impact factor: 3.584

2.  Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in Mice.

Authors:  Kemal Ertilav; Mustafa Nazıroğlu; Zeki Serdar Ataizi; Kenan Yıldızhan
Journal:  Biol Trace Elem Res       Date:  2020-06-23       Impact factor: 3.738

3.  Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 Channels.

Authors:  Pınar Aslan Koşar; Mustafa Nazıroğlu; İshak Suat Övey; Bilal Çiğ
Journal:  J Membr Biol       Date:  2015-11-02       Impact factor: 1.843

Review 4.  The role of melatonin in colorectal cancer treatment: a comprehensive review.

Authors:  Mindaugas Kvietkauskas; Viktorija Zitkute; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Ther Adv Med Oncol       Date:  2020-07-17       Impact factor: 8.168

Review 5.  Phytomelatonin: assisting plants to survive and thrive.

Authors:  Russel J Reiter; Dun-Xian Tan; Zhou Zhou; Maria Helena Coelho Cruz; Lorena Fuentes-Broto; Annia Galano
Journal:  Molecules       Date:  2015-04-22       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.